This calculator estimates GFR with the IDMS-traceable 4-variable MDRD equation in mL/min/1.73m², applied race-free. Read the full MDRD equation explained.
How to Use the MDRD Calculator
- Enter the patient’s age in years (adults only).
- Select sex; the equation applies a 0.742 multiplier for women.
- Enter serum creatinine and choose mg/dL or µmol/L; µmol/L is divided by 88.4 before the equation runs.
- Read the eGFR in mL/min/1.73m² with its KDIGO GFR category. A value above 60 is imprecise with MDRD, so many laboratories report it simply as “>60”.
What Is the MDRD Equation?
The Modification of Diet in Renal Disease (MDRD) Study equation estimates glomerular filtration rate from a blood test rather than a timed urine collection. It was developed in the 1990s from a large chronic kidney disease cohort and, for two decades, was the most widely reported eGFR equation in clinical laboratories. The IDMS-traceable 4-variable form re-calibrated the original equation to standardised creatinine assays. It reports a result in mL/min/1.73m², indexed to average adult body surface area.
How MDRD Works
The IDMS-traceable 4-variable MDRD equation is eGFR = 175 × Scr^−1.154 × age^−0.203 × (0.742 if female). Scr is serum creatinine in mg/dL, raised to the power −1.154 so that a higher creatinine lowers the estimate steeply. Age in years carries an exponent of −0.203, which applies the gradual decline in filtration with ageing. The 0.742 multiplier for women adjusts for their lower average creatinine production. We omit the historical race coefficient in line with the 2021 NKF-ASN recommendation.
Worked Example
For a 60-year-old man with a serum creatinine of 1.3 mg/dL, the equation gives 175 × 1.3^−1.154 × 60^−0.203, with no female multiplier. Working through the powers gives an eGFR of about 56 mL/min/1.73m². That value sits in the G3a band (45 to 59) and would be confirmed on a repeat sample before staging chronic kidney disease.
Serum Creatinine Units
MDRD expects serum creatinine in mg/dL. Convert from µmol/L by dividing by 88.4 (for example, 115 µmol/L ÷ 88.4 ≈ 1.3 mg/dL) using the unit converter. Entering the wrong unit shifts the estimate by a large factor, so check the unit on the report first.
How to Read an MDRD Result
An MDRD eGFR maps to the same KDIGO GFR categories used to stage chronic kidney disease:
| eGFR | Stage | Interpretation |
|---|---|---|
| ≥90 | G1 | Normal (MDRD is imprecise here; often reported as ">60") |
| 60 to 89 | G2 | Mildly reduced |
| 45 to 59 | G3a | Mild-to-moderate reduction |
| 30 to 44 | G3b | Moderate-to-severe reduction |
| 15 to 29 | G4 | Severely reduced |
| <15 | G5 | Kidney failure |
MDRD vs CKD-EPI: Which to Use
The newer CKD-EPI 2021 equation is more accurate near-normal GFR and is now the preferred first-line estimate. MDRD systematically underestimates GFR above 60 and is best treated as valid mainly below that threshold. MDRD remains useful for interpreting older records that reported it and for continuity in long-running datasets. For renal drug dosing, neither GFR equation replaces Cockcroft-Gault creatinine clearance, which most drug labels were validated against. Compare the two on MDRD vs CKD-EPI.
Limitations and Edge Cases
As a creatinine-based estimate indexed to 1.73m², MDRD shares the limitations of all such equations:
- Above 60 mL/min/1.73m²: imprecise, which is why many laboratories report “>60” rather than an exact value.
- Low muscle mass (amputees, frailty, paralysis): less creatinine is produced, so MDRD reads falsely high.
- High muscle mass or high-protein intake: more creatinine is produced, so MDRD may read falsely low.
- Acute kidney injury or any non-steady state: the equation assumes a stable creatinine and is not valid while the level is changing.
- Pregnancy and children: MDRD is not validated; pediatric estimates use the Schwartz equation instead.
Why MDRD Underestimates at Higher GFR
The MDRD Study equation was derived almost entirely from people who already had reduced kidney function, so it was fitted to the lower end of the GFR range. When applied to people with near-normal kidneys it systematically reads too low, often by a meaningful margin. That bias is why so many laboratories truncate the report at “>60” rather than print an exact value above that threshold: the equation is not precise enough there to justify a specific number. The newer CKD-EPI 2021 equation was built to correct this bias, and that is the main reason it is now preferred for first-line reporting.
Using an MDRD Result in Practice
Read an MDRD eGFR the same way you would any estimate: as a snapshot that needs confirmation before it changes management. If the value is below 60 mL/min/1.73m², the usual next steps are to repeat the test after about three months to confirm the change is sustained, to check urine albumin to grade kidney damage, and to review the clinical picture with a clinician. Where a record reports MDRD and a newer record reports CKD-EPI, expect the two to differ, particularly above 60, and avoid treating a change in equation as a real change in kidney function. For decisions that hinge on an accurate value near the normal range, recompute with CKD-EPI 2021.
Where You Still See MDRD Today
Although CKD-EPI 2021 is preferred for new reporting, MDRD remains common in older medical records, long-running research cohorts that kept one equation for consistency, and some laboratory systems that have not migrated. When comparing a patient's kidney function over several years, check which equation produced each value before reading a trend. A jump that coincides with a change of equation is usually an artefact of the method, not a real shift in filtration. For staging and management decisions, the safest approach is to recompute the most recent creatinine with the CKD-EPI 2021 equation so every value in the trend is on the same, more accurate footing.